Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XYL | Common Stock | Options Exercise | $1.07M | +21.8K | +28.58% | $49.23 | 98.1K | Jun 5, 2024 | Direct | |
transaction | XYL | Common Stock | Sale | -$3.03M | -21.8K | -22.23% | $139.01 | 76.3K | Jun 5, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XYL | Non-Qualified Stock Option (Right to Buy) | Options Exercise | $0 | -21.8K | -50% | $0.00 | 21.8K | Jun 5, 2024 | Common Stock | 21.8K | $49.23 | Direct | F2 |
Id | Content |
---|---|
F1 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 21,800 Shares were executed at a range of prices from $139.00 to $139.07. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
F2 | The February 14, 2020 option grant vested one fourth on January 1, 2021, January 1, 2022, January 1, 2023, and January 1, 2024. |